Teske S, Bohn AA, Regal JF, Neumiller JJ, Lawrence BP. 2005. Activation of the aryl hydrocarbon receptor increases pulmonary neutrophilia and diminishes host resistance to influenza a virus. American Journal of Physiology–Lung Cellular and Molecular Physiology 289(1):L111–L124.
Tonn T, Esser C, Schneider EM, Steinmann-Steiner-Haldenstatt W, Gleichmann E. 1996. Persistence of decreased T-helper cell function in industrial workers 20 years after exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Environmental Health Perspectives 104(4):422–426.
Van den Heuvel RL, Koppen G, Staessen JA, Hond ED, Verheyen G, Nawrot TS, Roels HA, Vlietinck R, Schoeters GE. 2002. Immunologic biomarkers in relation to exposure markers of PCBs and dioxins in Flemish adolescents (Belgium). Environmental Health Perspectives 110(6):595–600.
Viennot S, Deleporte A, Moussata D, Nancey S, Flourié B, Reimund JM. 2009. Colon cancer in inflammatory bowel disease: Recent trends, questions and answers. Gastroenterology and Clinical Biology 33 (Suppl 3):S190–S201.
Visintainer PF, Barone M, McGee H, Peterson EL. 1995. Proportionate mortality study of Vietnam-era veterans of Michigan. Journal of Occupational and Environmental Medicine 37(4):423–428.
Wang W, Bergh A, Damber JE. 2009. Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate. Prostate 69(13):1378–1386.
Webb K, Evans RG, Stehr P, Ayres SM. 1987. Pilot study on health effects of environmental 2,3,7,8-TCDD in Missouri. American Journal of Industrial Medicine 11:685–691.
Webb KZ, Evans RG, Knutsen AP, Roodman ST, Roberts DW, Schramm WF, Gibson BB, Andrews JS Jr, Needham LL, Patterson DG. 1989. Medical evaluation of subjects with known body levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Journal of Toxicology and Environmental Health 28:183–193.
Westbrook AM, Szakmary A, Schiestl RH. 2010. Mechanisms of intestinal inflammation and development of associated cancers: Lessons learned from mouse models. Mutation Research 705(1):40–59.
WHO (World Health Organization). 2006. Environmental Health Criteria 236. IPCS, Principles and Methods for Assessing Autoimmunity Associated with Exposure to Chemicals. Geneva: WHO Publications.
Wiklund FE, Bennet AM, Magnusson PK, Eriksson UK, Lindmark F, Wu L, Yaghoutyfam N, Marquis CP, Stattin P, Pedersen NL, Adami HO, Grönberg H, Breit SN, Brown DA. 2010. Macrophage inhibitory cytokine-1 (MIC-1/GDF15): A new marker of all-cause mortality. Aging Cell 9(6):1057–1064.
Winans B, Humble MC, Lawrence BP. 2010. Environmental toxicants and the developing immune system: A missing link in the global battle against infectious disease? Reproductive Toxicology 31(3):327–336.
Wolf N, Karmaus W. 1995. Effects of inhalative exposure to dioxins in wood preservatives on cell-mediated immunity in day-care center teachers. Environmental Research 68(2):96–105.
Wolfe WH, Lathrop GD, Albanese RA, Moynahan PM. 1985. An epidemiologic investigation of health effects in Air Force personnel following exposure to herbicides and associated dioxins. Chemosphere 14:707–716.
Wolfe WH, Michalek JE, Miner JC, Rahe A, Silva J, Thomas WF, Grubbs WD, Lustik MB, Karrison TG, Roegner RH, Williams DE. 1990. Health status of Air Force veterans occupationally exposed to herbicides in Vietnam. I. Physical health. Journal of the American Medical Association 264(14):1824–1831.
Wong PS, Vogel CF, Kokosinski K, Matsumura F. 2010. Arylhydrocarbon receptor activation in NCI-H441 cells and C57BL/6 mice: Possible mechanisms for lung dysfunction. American Journal of Respiratory Cell and Molecular Biology 42(2):210–217.
Zober A, Ott MG, Messerer P. 1994. Morbidity follow up study of BASF employees exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) after a 1953 chemical reactor incident. Occupational and Environmental Medicine 51(7):479–486.